Corinne Lafon

Development of a novel NURR1/NOT agonist from hit to lead and candidate for the potential treatment of Parkinson's disease.

M. Castel, P. Barnéoud, T. Rooney, 2019, Bioorganic & medicinal chemistry letters.

Involvement of p21 in the PKC‐induced regulation of the G2/M cell cycle transition

P. Chadebech, A. Valette, N. Barboule, 1999, FEBS letters.

Effect of the neuroprotective compound SR57746A on nerve growth factor synthesis in cultured astrocytes from neonatal rat cortex

P. Soubrié, G. Le Fur, P. Keane, 1999, British journal of pharmacology.